Radiation Oncology, Wayne State University, Detroit, Michigan, USA.
Oncology, Wayne State University, Detroit, Michigan, USA.
BMJ Case Rep. 2023 Jun 19;16(6):e253466. doi: 10.1136/bcr-2022-253466.
Intra-abdominal leiomyosarcomas (LMSs) are aggressive malignant tumours arising from smooth muscle cells. These neoplasms are extremely rare and account for 10%-20% of primary soft tissue sarcomas and approximately 0.1% of all colorectal malignancies. Intra-abdominal LMS has a very poor prognosis with an estimated 5-year survival rate between 20% and 50% and the size of the tumour being the main determinant of prognosis. Treatment is further complicated by different anatomic variants with differing clinical behaviours impacting prognosis. Newer techniques in radiation treatment such as intensity-modulated, intraoperative electron and proton beam radiotherapies allow for cases with high probability of local recurrence or likelihood of residual microscopic disease after surgical resection to be treated with precise radiation doses to the targeted tumour volume. We present a case of high grade LMS of the distal transverse colon with positive lymph node metastasis treated by surgical excision followed by adjuvant radiotherapy and discuss the current role of radiotherapy.
腹腔内平滑肌肉瘤(LMS)是一种起源于平滑肌细胞的侵袭性恶性肿瘤。这些肿瘤极为罕见,占原发性软组织肉瘤的 10%-20%,约占所有结直肠恶性肿瘤的 0.1%。腹腔内 LMS 预后极差,估计 5 年生存率在 20%-50%之间,肿瘤大小是预后的主要决定因素。由于不同解剖变异的存在,其临床行为也不同,从而影响预后,治疗变得更加复杂。放射治疗的新技术,如强度调制、术中电子和质子束放射治疗,允许对高局部复发概率或手术切除后残留微观疾病可能性的病例进行精确的靶向肿瘤体积放射治疗。我们报告了一例远端横结肠高级别 LMS,伴淋巴结转移,经手术切除后辅助放疗,讨论了放疗的现状。